Anonymous
Guest
Anonymous
Guest
It is pretty simple people the writing is on the wall. Give Reclast to CV reps, it will take at least a year for them to figure out what the heck it is indicated for, not to mention how to sell the damn thing. By that time everyone will be on PIP's and getting 1's for poor performance. With Diovan/Exforge going generic, most likely earlier than expected with a possible challenge by Teva, then add in a dash of Tekturna and every combo of it that you can think of going no where fast. BINGO! More PIP's and 1's to be given out. With Neuro/psych meds also going generic no need for 2 reps per territory there as well. With all of that and no blockbusters in the pipeline and no need for 5 chronic care reps per pod there goes another 1000 reps. Some through attrition others through firings and then maybe they will only have to lay off 500 by next year. Less reps per pod means less managers since they will be able to pick up 3 territories per district. It will be a quiet lay-off and wont seem that many are affected. Therefore, the package will not be as good as it was this year. Phase 2? Who knows, maybe even phase 3 by then. But when? The week after thanksgiving 2011 perhaps? Stay tuned.